Abstract:Abstract Background Neuroinflammation is thought to be a cause of Alzheimer’s disease (AD), which is partly caused by inadequate mitophagy. As a receptor of mitophagy, we aimed to reveal the regulatory roles of optineurin (OPTN) on neuroinflammation in the pathogenesis of AD. Methods BV2 cells and APP/PS1 transgenic (Tg) mice were used as in vitro and in vivo experimental models to determine the regulatory roles of OPTN in neuroinflammation of AD. Sophisticated molecular technologies including quantitative (q) RT-PCR, western blot, enzyme linked immunosorbent assay (ELISA), co-immunoprecipitation (Co-IP) and immunofluorescence (IF) were employed to reveal the inherent mechanisms. Results As a consequence, key roles of OPTN in regulating neuroinflammation were identified by depressing the activity of absent in melanoma 2 (AIM2) inflammasomes and receptor interacting serine/threonine kinase 1 (RIPK1)-mediated NF-κB inflammatory mechanisms. In detail, we found that expression of OPTN was downregulated, which resulted in activation of AIM2 inflammasomes due to a deficiency in mitophagy in APP/PS1 Tg mice. By ectopic expression, OPTN blocks the effects of Aβ oligomer (Aβo) on activating AIM2 inflammasomes by inhibiting mRNA expression of AIM2 and apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC), leading to a reduction in the active form of caspase-1 and interleukin (IL)-1β in microglial cells. Moreover, RIPK1 was also found to be negatively regulated by OPTN via ubiquitin protease hydrolysis, resulting in the synthesis of IL-1β by activating the transcriptional activity of NF-κB in BV2 cells. As an E3 ligase, the UBAN domain of OPTN binds to the death domain (DD) of RIPK1 to facilitate its ubiquitination. Based on these observations, ectopically expressed OPTN in APP/PS1 Tg mice deactivated microglial cells and astrocytes via the AIM2 inflammasome and RIPK-dependent NF-κB pathways, leading to reduce neuroinflammation. Conclusions These results suggest that OPTN can alleviate neuroinflammation through AIM2 and RIPK1 pathways, suggesting that OPTN deficiency may be a potential factor leading to the occurrence of AD.

Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling

The Diverse Role of Optineurin in Pathogenesis of Disease.

ALS-Associated E478G Mutation in Human OPTN (optineurin) Promotes Inflammation and Induces Neuronal Cell Death

Transcription factor E2F1 suppresses dendritic cell maturation.

Emodin Inhibits The Differentiation And Maturation Of Dendritic Cells And Increases The Production Of Regulatory T Cells

Optineurin regulates motor and learning behaviors by affecting dopaminergic neuron survival in mice

Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice

Osteopontin Regulates Development And Function Of Invariant Natural Killer T Cells

OPTN recruitment to a Golgi-proximal compartment regulates immune signalling and cytokine secretion

Optineurin Promotes Myogenesis During Muscle Regeneration in Mice by Autophagic Degradation of GSK3β

Exploring the Function of OPTN From Multiple Dimensions

Optineurin Regulates NRF2-mediated Antioxidant Response in a Mouse Model of Paget's Disease of Bone

Emerging views of OPTN (optineurin) function in the autophagic process associated with disease

Optineurin deficiency impairs autophagy to cause interferon beta overproduction and increased survival of mice following viral infection

TRIM14 Inhibits OPTN-mediated Autophagic Degradation of KDM4D to Epigenetically Regulate Inflammation.

Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget’s disease

Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone

Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration

Canonical Wnt Signaling in Dendritic Cells Regulates Th1/Th17 Responses and Suppresses Autoimmune Neuroinflammation.

Roles and mechanisms of optineurin in bone metabolism

Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway